drugset / Trial / NCT02959333

Human Amniotic Epithelial Cells for Treatment of Bronchial Fistula

NCT02959333 ↗

NaSingle-groupOpen-labelTreatment

Summary

Bronchial fistula (BF), an abnormal passage or communication between a bronchus and another part of the body, may develop when there are penetrating wounds of the thorax and after lung surgery. Without effective therapy, treatment of BF is a challenge, with a high rate of mortality and teratogenicity. The investigators will conduct endoscopic injection of human amniotic epithelial cells to fistula, observe the recovery of bronchial fistula and systemic reactions, to investigate the application of human amniotic epithelial cells in the treatment of bronchial fistula.

Timeline

Start
2016-10
Primary completion
2017-10
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject hAEC Cell therapy 3e+07 cells Other
Subject hAEC Cell therapy 5e+07 cells Other

Indications

No indication recorded.